184 related articles for article (PubMed ID: 24464752)
1. Ranolazine improves diastolic function in spontaneously hypertensive rats.
Williams S; Pourrier M; McAfee D; Lin S; Fedida D
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H867-81. PubMed ID: 24464752
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity.
Lovelock JD; Monasky MM; Jeong EM; Lardin HA; Liu H; Patel BG; Taglieri DM; Gu L; Kumar P; Pokhrel N; Zeng D; Belardinelli L; Sorescu D; Solaro RJ; Dudley SC
Circ Res; 2012 Mar; 110(6):841-50. PubMed ID: 22343711
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the late sodium current slows t-tubule disruption during the progression of hypertensive heart disease in the rat.
Aistrup GL; Gupta DK; Kelly JE; O'Toole MJ; Nahhas A; Chirayil N; Misener S; Beussink L; Singh N; Ng J; Reddy M; Mongkolrattanothai T; El-Bizri N; Rajamani S; Shryock JC; Belardinelli L; Shah SJ; Wasserstrom JA
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1068-79. PubMed ID: 23873796
[TBL] [Abstract][Full Text] [Related]
5. Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchange.
Soliman D; Wang L; Hamming KS; Yang W; Fatehi M; Carter CC; Clanachan AS; Light PE
J Pharmacol Exp Ther; 2012 Nov; 343(2):325-32. PubMed ID: 22879384
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest.
Fumagalli F; Russo I; Staszewsky L; Li Y; Letizia T; Masson S; Novelli D; Rocchetti M; Canovi M; Veglianese P; Gobbi M; Latini R; Zaza A; Ristagno G
Heart Rhythm; 2014 Sep; 11(9):1641-7. PubMed ID: 24858811
[TBL] [Abstract][Full Text] [Related]
7. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Wu Y; Song Y; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
[TBL] [Abstract][Full Text] [Related]
9. The onset of left ventricular diastolic dysfunction in SHR rats is not related to hypertrophy or hypertension.
Dupont S; Maizel J; Mentaverri R; Chillon JM; Six I; Giummelly P; Brazier M; Choukroun G; Tribouilloy C; Massy ZA; Slama M
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1524-32. PubMed ID: 22287586
[TBL] [Abstract][Full Text] [Related]
10. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.
Coppini R; Ferrantini C; Yao L; Fan P; Del Lungo M; Stillitano F; Sartiani L; Tosi B; Suffredini S; Tesi C; Yacoub M; Olivotto I; Belardinelli L; Poggesi C; Cerbai E; Mugelli A
Circulation; 2013 Feb; 127(5):575-84. PubMed ID: 23271797
[TBL] [Abstract][Full Text] [Related]
11. Late sodium current inhibition as a new cardioprotective approach.
Hale SL; Shryock JC; Belardinelli L; Sweeney M; Kloner RA
J Mol Cell Cardiol; 2008 Jun; 44(6):954-967. PubMed ID: 18462746
[TBL] [Abstract][Full Text] [Related]
12. Dietary-induced obesity hastens the progression from concentric cardiac hypertrophy to pump dysfunction in spontaneously hypertensive rats.
Majane OH; Vengethasamy L; du Toit EF; Makaula S; Woodiwiss AJ; Norton GR
Hypertension; 2009 Dec; 54(6):1376-83. PubMed ID: 19841294
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.
Fraser H; Belardinelli L; Wang L; Light PE; McVeigh JJ; Clanachan AS
J Mol Cell Cardiol; 2006 Dec; 41(6):1031-8. PubMed ID: 17027025
[TBL] [Abstract][Full Text] [Related]
14. New treatment options for late Na current, arrhythmias, and diastolic dysfunction.
Maier LS
Curr Heart Fail Rep; 2012 Sep; 9(3):183-91. PubMed ID: 22767404
[TBL] [Abstract][Full Text] [Related]
15. RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study.
Maier LS; Layug B; Karwatowska-Prokopczuk E; Belardinelli L; Lee S; Sander J; Lang C; Wachter R; Edelmann F; Hasenfuss G; Jacobshagen C
JACC Heart Fail; 2013 Apr; 1(2):115-22. PubMed ID: 24621836
[TBL] [Abstract][Full Text] [Related]
16. Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na
Nie J; Duan Q; He M; Li X; Wang B; Zhou C; Wu L; Wen Z; Chen C; Wang DW; Alsina KM; Wehrens XHT; Wang DW; Ni L
J Cell Physiol; 2019 Jul; 234(7):11587-11601. PubMed ID: 30488495
[TBL] [Abstract][Full Text] [Related]
17. Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats.
Li X; Han J; Li L; Wang KJ; Hu SJ
Int J Cardiol; 2013 Oct; 168(4):3340-7. PubMed ID: 23664044
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.
Belardinelli L; Shryock JC; Fraser H
Heart; 2006 Jul; 92 Suppl 4(Suppl 4):iv6-iv14. PubMed ID: 16775092
[TBL] [Abstract][Full Text] [Related]
19. Improvement in left ventricular systolic and diastolic performance during ranolazine treatment in patients with stable angina.
Figueredo VM; Pressman GS; Romero-Corral A; Murdock E; Holderbach P; Morris DL
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):168-72. PubMed ID: 20924097
[TBL] [Abstract][Full Text] [Related]
20. 18β-Glycyrrhetinic Acid Improves Cardiac Diastolic Function by Attenuating Intracellular Calcium Overload.
Han J; Su GH; Wang YH; Lu YX; Zhao HL; Shuai XX
Curr Med Sci; 2020 Aug; 40(4):654-661. PubMed ID: 32862375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
